Literature DB >> 15459585

Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction.

Kai Marten Eggers1, Jonas Oldgren, Anna Nordenskjöld, Bertil Lindahl.   

Abstract

BACKGROUND: Despite improved laboratory assays for cardiac markers and a revised standard for definition of myocardial infarction (AMI), early detection of coronary ischemia in unselected patients with chest pain remains a difficult challenge.
METHODS: Rapid measurements of troponin I (TnI), creatine kinase MB (CK-MB), and myoglobin were performed in 197 consecutive patients with chest pain and a nondiagnostic electrocardiogram for AMI. The early diagnostic performances of these markers and different multimarker strategies were evaluated and compared. Diagnosis of AMI was based on European Society of Cardiology/American College of Cardiology criteria.
RESULTS: At a given specificity of 95%, TnI yielded the highest sensitivity of all markers at all time points. A TnI cutoff corresponding to the 10% coefficient of variation (0.1 microg/L) demonstrated a cumulative sensitivity of 93% with a corresponding specificity of 81% at 2 hours. The sensitivity was considerably higher compared to CK-MB and myoglobin, even considering patients with a short delay until admission. Using the 99th percentile of TnI results as a cutoff (0.07 microg/L) produced a cumulative sensitivity of 98% at 2 hours, but its usefulness was limited due to low specificities. Multimarker strategies including TnI and/or myoglobin did not provide a superior overall diagnostic performance compared to TnI using the 0.1 microg/L cutoff.
CONCLUSION: A TnI cutoff corresponding to the 10% coefficient of variation was most appropriate for early diagnosis of AMI. A lower TnI cutoff may be useful for very early exclusion of AMI. CK-MB and in particular myoglobin did not offer additional diagnostic value.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459585     DOI: 10.1016/j.ahj.2004.04.030

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  33 in total

1.  A review of troponins in ischemic heart disease and other conditions.

Authors:  Nedaa Skeik; Deevia Chandrakant Patel
Journal:  Int J Angiol       Date:  2007

2.  Acute coronary syndromes: Troponin triumphant?

Authors:  Paul O Collinson
Journal:  Nat Rev Cardiol       Date:  2009-12       Impact factor: 32.419

Review 3.  Identification of myocardial injury in the emergency setting.

Authors:  Peter A Kavsak; Andrew Worster; John J You; Mark Oremus; Adell Elsharif; Stephen A Hill; P J Devereaux; Andrew R MacRae; Allan S Jaffe
Journal:  Clin Biochem       Date:  2009-12-21       Impact factor: 3.281

Review 4.  Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review.

Authors:  Christopher Layfield; John Rose; Aaron Alford; Susan R Snyder; Fred S Apple; Farah M Chowdhury; Michael C Kontos; L Kristin Newby; Alan B Storrow; Milenko Tanasijevic; Elizabeth Leibach; Edward B Liebow; Robert H Christenson
Journal:  Clin Biochem       Date:  2015-02-07       Impact factor: 3.281

5.  The prevalence of the cardiac origin of chest pain: the experience of a rural area of southeast Italy.

Authors:  Chiara Cilia; Lorenzo S Malatino; Giuseppe Puccia; Maria Anna Iurato; Giovanni Noto; Giovanni Tripepi; Peter Rosen; Benedetta Stancanelli
Journal:  Intern Emerg Med       Date:  2010-05-07       Impact factor: 3.397

Review 6.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

7.  Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients.

Authors:  Tobias Breidthardt; James O Burton; Aghogho Odudu; Mohamed Tarek Eldehni; Helen J Jefferies; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

Review 8.  The utility of troponin measurement to detect myocardial infarction: review of the current findings.

Authors:  Melissa A Daubert; Allen Jeremias
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

9.  Appropriate pathology ordering? Troponin testing within an Australian Emergency Department.

Authors:  F W Gardiner; S Zhai
Journal:  Ir J Med Sci       Date:  2016-06-24       Impact factor: 1.568

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.